Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Poulin Joshua

70 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 39 Safety 25 Clinical Trial 22 Treatment-Resistant Depression 19 Review Article 16 Observational Study 14 Anxiety 13 Aging 11 Addiction 10 Adverse Events 10 Pharmacology 9 Brain Imaging 8

Journals

Biological Psychiatry 8 ClinicalTrials.gov 6 Psychedelic medicine (New Rochelle, N.Y.) 3 Scientific reports 3 JAMA psychiatry 2 JAMA 2 Journal of psychoactive drugs 2 Journal of psychopharmacology (Oxford, England) 2

Publication history

The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseClinicalTrials.gov · 2026-08-07 Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant DepressionClinicalTrials.gov · 2026-07-30 Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.JAMA psychiatry · 2026-07-01 Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.Proceedings of the National Academy of Sciences of the United States of America · 2026-06-16 Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-06-01 483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-AnalysisBiological Psychiatry · 2026-05-01 A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back PainClinicalTrials.gov · 2026-04-29 Fusing Specialized Surveys of Rare Populations to Larger Surveys for Generalized Inference: Cross-Sectional Survey Study.Journal of medical Internet research · 2026-04-27 Psilocybin Trends in States That Decriminalized UseJAMA · 2026-04-14 An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01 Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT).Journal of psychoactive drugs · 2026-03-16 Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System®, 2023-2024.Clinical toxicology (Philadelphia, Pa.) · 2026-03-01 Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-03-01 From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.Translational behavioral medicine · 2026-01-07 Mechanisms of psilocybin on the treatment of posttraumatic stress disorder.Journal of psychopharmacology (Oxford, England) · 2026-01-01 Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.General hospital psychiatry · 2026-01-01 Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20 The Role of Touch in Psychedelic Therapy: Perspectives From a Survey of Practitioners in Research Settings.American journal of psychotherapy · 2025-12-15 Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2025-10-01 Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2025-09-01 Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-07-01 The Rise of Psilocybin Use in the United States: A Multisource Observational Study.Annals of internal medicine · 2025-07-01 Psilocybin With Intracranial Neural SensingClinicalTrials.gov · 2025-06-06 Polysubstance Use Profiles Among the General Adult Population, United States, 2022.American journal of public health · 2025-05-01 188. Mapping Psilocybin Therapy: A Systematic Review of Therapeutic Frameworks, Adaptations, and Standardization Across Contemporary Clinical TrialsBiological Psychiatry · 2025-04-09 Precision Functional Mapping of Psilocybin’s Acute and Persistent Brain EffectsBiological Psychiatry · 2025-04-09 194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-09 187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-09 186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-09 323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study ParticipationBiological Psychiatry · 2025-04-09 Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01 A qualitative analysis of the psychedelic mushroom come-up and come-down.Npj mental health research · 2025-02-07 Psychological Support Approaches in Psychedelic Therapy: Results From a Survey of Psychedelic Practitioners.The Journal of clinical psychiatry · 2025-02-05 The Acceptability of Psychedelic-Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour.International journal of mental health nursing · 2025-02-01 Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot StudyClinicalTrials.gov · 2025-01-01 : A new species from central Florida, with notes on and.Mycologia · 2025-01-01 Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional propertiesNature Mental Health · 2024-10-14 Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.Psychopharmacology · 2024-08-01 Psilocybin desynchronizes the human brain.Nature · 2024-08-01 Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.Trials · 2024-07-03 A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?Psychedelic medicine (New Rochelle, N.Y.) · 2024-06-01 Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.JAMA network open · 2024-04-01 Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08 Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometryJournal of Analytical Toxicology · 2024-03-01 Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Journal of psychoactive drugs · 2024-01-01 Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury.Military medicine · 2023-11-03 "But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.The International journal of eating disorders · 2023-11-01 Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05 Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin.Cureus · 2023-09-01 Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.BJPsych open · 2023-07-25 Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.The American journal of psychiatry · 2023-05-01 Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice.Psychedelic medicine (New Rochelle, N.Y.) · 2023-03-01 Considerations in assessing the abuse potential of psychedelics during drug development.Neuropharmacology · 2023-02-15 Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample.Scientific reports · 2023-02-11 The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2023-01-01 Psychedelic Drug Legislative Reform and Legalization in the US.JAMA psychiatry · 2023-01-01 The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Psychiatry research · 2022-07-01 Associations between classic psychedelics and nicotine dependence in a nationally representative sample.Scientific reports · 2022-06-22 Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.Scientific reports · 2022-04-07 Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.Journal of the neurological sciences · 2022-03-15 Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.CNS drugs · 2022-01-01 A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Journal of clinical psychopharmacology · 2022-01-01 Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience.ACS pharmacology & translational science · 2021-04-09 Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case StudiesmedRxiv · 2021-04-07 Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS SurvivorsClinicalTrials.gov · 2021-01-07 Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.Frontiers in neuroergonomics · 2021-01-01 The emerging role of psilocybin and MDMA in the treatment of mental illness.Expert review of neurotherapeutics · 2020-12-01 Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.EClinicalMedicine · 2020-10-01 Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity.Biological psychiatry · 2020-07-15 T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS SurvivorsBiological Psychiatry · 2019-04-30

Author directory